This study investigates the hypothesis that presence of atrial fibrillation (AF) in LVAD patients increases thrombogenicity in the left ventricle (LV) and exacerbates stroke risk.
Methods:
Using an anatomical LV model implanted with an LVAD inflow cannula, we analyze thrombogenic risk and blood flow patterns in either AF or sinus rhythm (SR) using unsteady computational fluid dynamics (CFD). To analyze platelet activation and thrombogenesis in the LV, hundreds of thousands of platelets are individually tracked to quantify platelet residence time (RT) and shear stress accumulation history (SH).
Results:
The irregular and chaotic mitral inflow associated with AF results in markedly different intraventricular flow patterns, with profoundly negative impact on blood flow-induced stimuli experienced by platelets as they traverse the LV. Twice as many platelets accumulated very high SH in the LVAD + AF case, resulting in a 36% increase in thrombogenic potential score, relative to the LVAD + SR case.
Conclusions:
This supports the hypothesis that AF results in unfavorable blood flow patterns in the LV adding to an increased stroke risk for LVAD + AF patients. Quantification of thrombogenic risk associated with AF for LVAD patients may help guide clinical decision-making on interventions to mitigate the increased risk of thromboembolic events.
BenjaminEJViraniSSCallawayCW, et al. Heart disease and stroke statistics—2018 update: a report from the american heart association. Circulation2018; 137(12): e67–e492.
2.
ManciniDColomboPC.Left ventricular assist devices: a rapidly evolving alternative to transplant. J Am Coll Cardiol2015; 65: 2542–2555.
3.
NajjarSSSlaughterMSPaganiFD, et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant2014; 33: 23–34.
4.
MehraMRStewartGCUberPA.The vexing problem of thrombosis in long-term mechanical circulatory support. J Hear Lung Transplant2014; 33: 1–11.
5.
BlitzA.Pump thrombosis—a riddle wrapped in a mystery inside an enigma. Ann Cardiothorac Surg2014; 2: 450–471.
6.
WangTJLarsonMGLevyD, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study. Circulation2003; 107: 2920–2925.
7.
MarroucheNFBrachmannJAndresenD, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med2018; 378: 417–427.
8.
JanuaryCTWannLSAlpertJS, et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. J Am Coll Cardiol2014; 64: e1–e76.
9.
GladstoneDJSpringMDorianP, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med2014; 370: 2467–2477.
10.
SannaTDienerH-CPassmanRS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med2014; 370: 2478–2486.
11.
HartRGDienerH-CCouttsSB, et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol2014; 13: 429–438.
12.
DeshmukhABhatiaAAnyanwuE, et al. Incidence and outcomes of postoperative atrial fibrillation after left ventricular assist device. ASAIO J2018; 64(5): 581–585.
13.
KohSBraunOOBrambattiM, et al. Atrial fibrillation is associated with early right ventricular failure post-LVAD. J Hear Lung Transplant2018; 37: S131.
14.
WehbeRMTibrewalaAAndersonAS, et al. Atrial fibrillation increases risk of recurrent heart failure readmissions in LVAD patients. J Hear Lung Transplant2018; 37: S380–S381.
15.
JanuaryCTWannLSCalkinsH, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Circulation2019; 140(2): e125–e151.
16.
GiuliaNSMandoliESciaccalugaC, et al. Insight into atrial fibrillation in LVAD patients: from clinical implications to prognosis. Pulse2020; 8: 2–14.
17.
MehraMRGoldsteinDJUrielN, et al. Two-year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med2018; 378: 1386–1395.
18.
PotapovEVSchoenrathF.Atrial fibrillation in patients on left ventricular assist device support—to treat or not to treat. Eur J Cardio-Thoracic Surg2022; 61: 1176–1177.
19.
ChivukulaVKBeckmanJAPriscoARC, et al. Left ventricular assist device inflow cannula angle and thrombosis risk. Circ Heart Fail2018; 11: e004325.
20.
ChivukulaVKBeckmanJAPriscoAR, et al. Small left ventricular size is an independent risk factor for ventricular assist device thrombosis. ASAIO J2019; 65(2): 152–159.
21.
MarklMCarrMNgJ, et al. Assessment of left and right atrial 3D hemodynamics in patients with atrial fibrillation: a 4D flow MRI study. Int J Cardiovasc Imaging2016; 32: 807–815.
22.
FluckigerJUGoldbergerJJLeeDC, et al. Left atrial flow velocity distribution and flow coherence using four-dimensional FLOW MRI: a pilot study investigating the impact of age and Pre- and Postintervention atrial fibrillation on atrial hemodynamics. J Magn Reson Imaging2013; 38: 580–587.
23.
ScarsoglioSCamporealeCGualaA, et al. Fluid dynamics of heart valves during atrial fibrillation: a lumped parameter-based approach. Comput Methods Biomech Biomed Engin2016; 19: 1060–1068.
24.
ScarsoglioSGualaACamporealeC, et al. Impact of atrial fibrillation on the cardiovascular system through a lumped-parameter approach. Med Biol Eng Comput2014; 52: 905–920.
25.
KoizumiRFunamotoKHayaseT, et al. Numerical analysis of hemodynamic changes in the left atrium due to atrial fibrillation. J Biomech2015; 48: 472–478.
26.
SheriffJSoaresJSXenosM, et al. Evaluation of shear-induced platelet activation models under constant and dynamic shear stress loading conditions relevant to devices. Ann Biomed Eng2013; 41: 1279–1296.
27.
RowleyJWFinnA VFrenchPA, et al. Cardiovascular devices and platelet interactions understanding the role of injury, flow, and cellular responses. Circ Cardiovasc Interv2012; 5: 296–304.
28.
XenosMGirdharGAlemuY, et al. Device Thrombogenicity Emulator (DTE)—design optimization methodology for cardiovascular devices: a study in two bileaflet MHV designs. J Biomech2010; 43: 2400–2409.
29.
ChivukulaVKBeckmanJALiS, et al. Left ventricular assist device inflow cannula insertion depth influences thrombosis risk. ASAIO J2020; 66: 766–773.
30.
ChassagneFMiramontesMChivukulaVK, et al. In vitro investigation of the effect of left ventricular assist device speed and pulsatility mode on intraventricular hemodynamics. Ann Biomed Eng2021; 49: 1318–1332.
31.
ShankaranHAlexandridisPNeelameghamS.Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension. Blood2003; 101: 2637–2645.
32.
RamstackJMZuckermanLMockrosLF.Shear-induced activation of platelets. J Biomech1979; 12: 113–125.
33.
SelmiMChiuW-CChivukulaVK, et al. Blood damage in left ventricular assist devices: pump thrombosis or system thrombosis?Int J Artif Organs2019; 42(3): 113–124.
34.
AlisedaAChivukulaVMcgahP, et al. LVAD outflow graft angle and thrombosis risk. ASAIO J2017; 63: 14–23.
35.
MahrCChivukulaVKMcGahP, et al. Intermittent aortic valve opening and risk of thrombosis in VAD patients. ASAIO J2017; 63: 425–432.
36.
ShahPTantryUSBlidenKP, et al. Bleeding and thrombosis associated with ventricular assist device therapy. J Heart Lung Transplant2017; 33: 80–87.
37.
FronteraJAStarlingRChoS-M, et al. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices. J Hear Lung Transplant2017; 36: 673–683.
38.
StulakJMDeoSSchirgerJ, et al. Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation. Ann Thorac Surg2013; 96: 2161–2167.
39.
CherianTSShraderPFonarowGC, et al. Effect of atrial fibrillation on mortality, stroke risk, and quality-of-life scores in patients with heart failure (from the outcomes registry for better informed treatment of atrial fibrillation [ORBIT-AF]). Am J Cardiol2017; 119: 1763–1769.
40.
BecattiniCDentaliFCamporeseG, et al. Carotid atherosclerosis and risk for ischemic stroke in patients with atrial fibrillation on oral anticoagulant treatment. Atherosclerosis2018; 271: 177–181.
41.
ChoiHWNaviaJAKassabGS.Stroke propensity is increased under atrial fibrillation hemodynamics: a simulation study. PLoS ONE2013; 8: 1–11.
42.
LiLYiinGSGeraghtyOC, et al. Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study. Lancet Neurol2015; 14: 903–913.
